CME Group Inc. (CME) Shares Sold by Capital World Investors
Capital World Investors reduced its position in CME Group Inc. (NASDAQ:CME) by 4.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,850,381 shares of the financial services provider’s stock after selling 1,576,357 shares during the quarter. CME Group makes up about 0.9% of Capital World Investors’ investment portfolio, making the stock its 23rd biggest holding. Capital World Investors owned approximately 9.08% of CME Group worth $3,863,702,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in CME. RMB Capital Management LLC lifted its holdings in CME Group by 3.1% during the 1st quarter. RMB Capital Management LLC now owns 114,834 shares of the financial services provider’s stock worth $13,642,000 after buying an additional 3,501 shares during the last quarter. Capital Advisors Inc. OK grew its position in shares of CME Group by 10.7% in the 2nd quarter. Capital Advisors Inc. OK now owns 84,533 shares of the financial services provider’s stock worth $10,587,000 after acquiring an additional 8,198 shares in the last quarter. Marvin & Palmer Associates Inc. grew its position in shares of CME Group by 100.7% in the 2nd quarter. Marvin & Palmer Associates Inc. now owns 57,278 shares of the financial services provider’s stock worth $7,173,000 after acquiring an additional 28,745 shares in the last quarter. Thrivent Financial For Lutherans increased its holdings in shares of CME Group by 5.6% in the 1st quarter. Thrivent Financial For Lutherans now owns 12,500 shares of the financial services provider’s stock valued at $1,485,000 after acquiring an additional 660 shares during the last quarter. Finally, Captrust Financial Advisors bought a new stake in shares of CME Group in the 2nd quarter valued at approximately $693,000. 82.64% of the stock is owned by hedge funds and other institutional investors.
CME Group Inc. (CME) traded up 0.10% during trading on Monday, hitting $135.82. 222,482 shares of the stock traded hands. The stock has a market cap of $46.17 billion, a PE ratio of 27.72 and a beta of 0.73. The company has a 50-day moving average price of $126.73 and a 200 day moving average price of $122.14. CME Group Inc. has a one year low of $98.95 and a one year high of $136.26.
CME Group (NASDAQ:CME) last posted its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.03. The business had revenue of $925.00 million during the quarter, compared to the consensus estimate of $931.05 million. CME Group had a return on equity of 7.61% and a net margin of 46.05%. CME Group’s revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the company earned $1.14 EPS. Analysts expect that CME Group Inc. will post $4.82 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Monday, September 25th. Shareholders of record on Friday, September 8th were paid a dividend of $0.66 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $2.64 annualized dividend and a yield of 1.95%. CME Group’s dividend payout ratio is currently 53.99%.
In other news, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, July 10th. The stock was sold at an average price of $124.50, for a total value of $311,250.00. Following the transaction, the chief financial officer now directly owns 38,495 shares of the company’s stock, valued at approximately $4,792,627.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Bryan T. Durkin sold 9,200 shares of the business’s stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $125.13, for a total value of $1,151,196.00. Following the completion of the transaction, the president now directly owns 70,938 shares in the company, valued at $8,876,471.94. The disclosure for this sale can be found here. Insiders have sold 48,244 shares of company stock valued at $6,021,890 over the last quarter. Corporate insiders own 0.57% of the company’s stock.
Several equities analysts recently issued reports on CME shares. UBS AG restated a “buy” rating and set a $134.00 price objective (down from $136.00) on shares of CME Group in a research note on Monday, June 5th. BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, September 27th. Keefe, Bruyette & Woods reissued a “hold” rating and set a $127.00 target price on shares of CME Group in a report on Friday, August 18th. Royal Bank Of Canada set a $135.00 target price on shares of CME Group and gave the stock a “buy” rating in a report on Tuesday, August 1st. Finally, Jefferies Group LLC restated a “buy” rating and issued a $128.00 price target on shares of CME Group in a research report on Monday, July 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. CME Group presently has a consensus rating of “Buy” and a consensus price target of $133.22.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.